These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8542045)

  • 21. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.
    Jones KJ; Morgan G; Johnston H; Tobias V; Ouvrier RA; Wilkinson I; North KN
    J Med Genet; 2001 Oct; 38(10):649-57. PubMed ID: 11584042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects.
    Reed UC
    Arq Neuropsiquiatr; 2009 Mar; 67(1):144-68. PubMed ID: 19330236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of laminin beta 2 chain expression in congenital muscular dystrophy.
    Cohn RD; Herrmann R; Wewer UM; Voit T
    Neuromuscul Disord; 1997 Sep; 7(6-7):373-8. PubMed ID: 9327401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laminin-alpha 2 chain (merosin M) is preserved in the Walker-Warburg syndrome.
    Kükner S; Gürer Y; Saatçi I; Akçören Z; Topaloğlu H
    Neuropediatrics; 1996 Oct; 27(5):279-80. PubMed ID: 8971752
    [No Abstract]   [Full Text] [Related]  

  • 25. Merosin-positive congenital muscular dystrophy with mental retardation and cataracts: a new entity in two families.
    Topaloğlu H; Yetük M; Talim B; Akçören Z; Cağlar M
    Eur J Paediatr Neurol; 1997; 1(4):127-31. PubMed ID: 10728208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital muscular dystrophy with merosin deficiency.
    Tomé FM; Evangelista T; Leclerc A; Sunada Y; Manole E; Estournet B; Barois A; Campbell KP; Fardeau M
    C R Acad Sci III; 1994 Apr; 317(4):351-7. PubMed ID: 8000914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Merosin negative congenital muscular dystrophy: a short report.
    Ralte AM; Sharma MC; Gulati S; Das M; Sarkar C
    Neurol India; 2003 Sep; 51(3):417-9. PubMed ID: 14652462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual function in children with merosin-deficient and merosin-positive congenital muscular dystrophy.
    Mercuri E; Anker S; Philpot J; Sewry C; Dubowitz V; Muntoni F
    Pediatr Neurol; 1998 May; 18(5):399-401. PubMed ID: 9650678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Merosin and congenital muscular dystrophy.
    Miyagoe-Suzuki Y; Nakagawa M; Takeda S
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):181-91. PubMed ID: 10679965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic identity of Fukuyama-type congenital muscular dystrophy and Walker-Warburg syndrome.
    Toda T; Yoshioka M; Nakahori Y; Kanazawa I; Nakamura Y; Nakagome Y
    Ann Neurol; 1995 Jan; 37(1):99-101. PubMed ID: 7818265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe congenital muscular dystrophy in a LAMA2-mutated case.
    Di Blasi C; van Alfen N; Colleoni F; ter Laak H; Mora M
    Pediatr Neurol; 2007 Sep; 37(3):212-4. PubMed ID: 17765811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital muscular dystrophy: use of brain MR imaging findings to predict merosin deficiency.
    Lamer S; Carlier RY; Pinard JM; Mompoint D; Bagard C; Burdairon E; Estournet B; Barois A; Vallée C
    Radiology; 1998 Mar; 206(3):811-6. PubMed ID: 9494506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital muscular dystrophy with primary partial laminin alpha2 chain deficiency: molecular study.
    He Y; Jones KJ; Vignier N; Morgan G; Chevallay M; Barois A; Estournet-Mathiaud B; Hori H; Mizuta T; Tomé FM; North KN; Guicheney P
    Neurology; 2001 Oct; 57(7):1319-22. PubMed ID: 11591858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non-Fukuyama type congenital muscular dystrophy--merosin deficient and positive forms].
    Nonaka I
    Nihon Rinsho; 1997 Dec; 55(12):3176-80. PubMed ID: 9436431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A unique case of congenital muscular dystrophy].
    Hermanová M; Vondrácek P; Lukás Z
    Cesk Patol; 2004 Apr; 40(2):57-62. PubMed ID: 15233018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular genetics and merosin abnormality in Fukuyama-type congenital muscular dystrophy (FCMD)].
    Toda T; Kobayashi K
    Nihon Rinsho; 1997 Dec; 55(12):3169-75. PubMed ID: 9436430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities.
    Sunada Y; Edgar TS; Lotz BP; Rust RS; Campbell KP
    Neurology; 1995 Nov; 45(11):2084-9. PubMed ID: 7501163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy.
    Sewry CA; D'Alessandro M; Wilson LA; Sorokin LM; Naom I; Bruno S; Ferlini A; Dubowitz V; Muntoni F
    Neuropediatrics; 1997 Aug; 28(4):217-22. PubMed ID: 9309712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital myopathies and muscular dystrophies.
    Gilbreath HR; Castro D; Iannaccone ST
    Neurol Clin; 2014 Aug; 32(3):689-703, viii. PubMed ID: 25037085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital muscular dystrophy with characteristic radiological findings similar to those with Fukuyama congenital muscular dystrophy.
    Garg A; Gulati S; Gupta V; Kalra V
    Neurol India; 2004 Dec; 52(4):496-8. PubMed ID: 15626844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.